2025 was a significant year for Venture Life, with the company disposing of its contract development and manufacturing organisation (CDMO) along with some non-core brands and subsequently completing the divestment of its oral care brands, UltraDEX and Dentyl. With these disposals completed, Venture Life has sharpened its focus on the Proactive Healthy Longevity market, with a portfolio of brands to target this high growth, high margin opportunity. Cash receipts from the disposals alongside organ ....
